 BOTHELL, Wash., March 21, 2022 GLOBE NEWSWIRE -- Athira Pharma, Inc. NASDAQ: ATHA, a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that members of Athira Pharmas senior management team will participate in the following upcoming investor conferences. 